Global Intrauterine Devices Market, By Type; By End User; By Region; Trend Analysis, Competitive Market Share & Forecast, 2021-2027

Intrauterine Devices (IUDs) Market is Projected to Reach USD 5.89 Billion by 2027, Growing at a CAGR of 5.1% During 2021-2027

According to the author, the global Intrauterine Devices (IUDs) market is estimated to have reached USD 4.23 billion in 2020 and is further projected to reach USD 5.89 billion by 2027, growing at a CAGR of 5.1% during 2021-2027 (forecast period). IUD"means "intrauterine device."These devices are shaped like a "T"and a bit bigger than a quarter, an IUD fits inside the uterus. It prevents pregnancy by stopping sperm from reaching and fertilizing eggs. These devices are a form of long-acting reversible contraceptives that help in birth control. IUDs can also last for an extended period of 5 to 10 years, depending on the type. The hormones or copper in these devices change the cervical mucus lining and helps in the prevention of pregnancy.

Advantages associated with Intrauterine Devices market

IUDs protect against pregnancy for 5 or 10 years, depending on the type. Once an IUD is fitted, it works straight away. Most women can use it. There are no hormonal side effects, such as acne, headaches, or breast tenderness. It's safe to use an IUD if the women are breastfeeding. It's possible to get pregnant as soon as the IUD is removed. Also, it's not affected by other medicines. They are more than 99% effective in preventing pregnancy. There's no evidence that an IUD will affect your weight or increase the risk of cervical cancer, cancer of the uterus, or ovarian cancer.

Pelvic inflammatory Infection

The pelvic inflammatory disease (PID) has been associated with the use of IUDs ever since they were introduced. There is a small increased risk of pelvic infection after the insertion of an IUD. This risk is generally confined to the first three weeks after insertion. The other major restraints associated with IUDs include that the periods may become heavier, longer, or more painful, though this may improve after a few months. It does not protect against STIs, so may need to use condoms as well. If it gets an infection when women have an IUD fitted, it could lead to a pelvic infection if not treated.

Hormonal Intrauterine Device Segment occupy the largest share of the Intrauterine Devices market

Based on the type, the Intrauterine Devices market is segmented into Hormonal Intrauterine Device, Copper Intrauterine Device. The Hormonal intrauterine device segment followed by Copper Intrauterine Device is likely to dominate the Intrauterine Devices market. The hormonal intrauterine device is a T-shaped plastic frame that's inserted into the uterus, where it releases a type of the hormone progestin. To prevent pregnancy, Mirena, a commonly used hormonal intrauterine device thickens the mucus in the cervix to stop sperm from reaching or fertilizing an egg. Thins the lining of the uterus and partially suppresses ovulation

Global Intrauterine Devices Market: Regional insights

North America catering the largest share and expected to witness significant growth in the Intrauterine Devices market during the forecast period. The high industry growth rate, with the emergence of new technology, is the major reason. The key providers are continuously upgrading their offerings to differentiate them from other competitors. This is achieved by various organic and inorganic strategies. Suppliers operating in the industry are continuously working on new development, technical expertise, and in-house capabilities. High opportunity makes the Intrauterine Devices market more competitive and suppliers are trying hard to capture the clients. The market is highly acceptable to innovative products, however, considering the risks involved in business continuity implementers are still considering brand over new offerings in the market.

Global Intrauterine Devices Market: Competitive Landscape

The leading players in the global Intrauterine Devices market include Allergan PLC, Bayer AG, CooperSurgical Inc., DKT International, Egemen International, Mona Lisa NV, Pregna International Limited, Prosan International BV, and SMB Corporation of India. OCON Medical, Pregna, SMB Corporation, HLL Lifecare, HRA Pharma, Besins HealthCare, are expanding their presence in the market by implementing various business strategies. Major players are engaged in mergers and acquisitions, expansion of their manufacturing facilities, infrastructural growth, investment in R&D facilities, and the quest for opportunities to expand vertically through the value chain.

Don’t miss the business opportunity in the Intrauterine Devices market. Consult our analysts, gain crucial insights, and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of global Intrauterine Devices market size & forecast. The report promises to provide recent technology trends in the Intrauterine Devices market and industry insights that help decision-makers to make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


This product will be delivered within 2 business days.